Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7562)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2014 (publication date) through Apr 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | García-Albéniz X, Gallego R, Hofheinz RD, Fernández-Esparrach G, Ayuso-Colella JR, Bombí JA, Conill C, Cuatrecasas M, Delgado S, Ginés A, Miquel R, Pagés M, Pineda E, Pereira V, Sosa A, Reig O, Victoria I, Feliz L, María de Lacy A, Castells A, Burkholder I, Hochhaus A, Maurel J. Adjuvant therapy sparing in rectal cancer achieving complete response after chemoradiation. World J Gastroenterol 2014; 20(42): 15820-15829 [PMID: 25400468 DOI: 10.3748/wjg.v20.i42.15820] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i42/15820.htm |
| Number | Citing Articles |
| 1 |
Julio Garcia-Aguilar, Rob Glynne-Jones, Deborah Schrag. Multimodal Rectal Cancer Treatment: In Some Cases, Less May Be More. American Society of Clinical Oncology Educational Book 2016; (36): 92 doi: 10.1200/EDBK_159221
|
| 2 |
Yu Jin Lim, Youngkyong Kim, Moonkyoo Kong. Adjuvant chemotherapy in rectal cancer patients who achieved a pathological complete response after preoperative chemoradiotherapy: a systematic review and meta-analysis. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-46457-5
|
| 3 |
Samer A. Naffouje, Yuen-Joyce Liu, Sivesh K. Kamarajah, George I. Salti, Fadi Dahdaleh. Adjuvant chemotherapy after neoadjuvant chemoradiation and proctectomy improves survival irrespective of pathologic response in rectal adenocarcinoma: a population-based cohort study. International Journal of Colorectal Disease 2022; 37(10): 2137 doi: 10.1007/s00384-022-04245-0
|
| 4 |
Nadine Jackson McCleary, Al B. Benson, Rodrigo Dienstmann. Personalizing Adjuvant Therapy for Stage II/III Colorectal Cancer. American Society of Clinical Oncology Educational Book 2017; (37): 232 doi: 10.1200/EDBK_175660
|
| 5 |
Nina N. Sanford, Todd A. Aguilera, Muhammad S. Beg, Aravind Sanjeevaiah, Theodore S. Hong, Jennifer Y. Wo, Michael R. Folkert. Patterns of Care for Stage II-III Rectosigmoid Cancers in the United States, 2004-2015. American Journal of Clinical Oncology 2020; 43(5): 311 doi: 10.1097/COC.0000000000000674
|
| 6 |
Chao Xiao, Yupeng Wang, Miao Zheng, Jian Chen, Guohe Song, Zhijie Zhou, Chongzhi Zhou, Xing Sun, Lin Zhong, Erxun Ding, Yi Zhang, Liu Yang, Gang Wu, Shifeng Xu, Hong Zhang, Xiaoliang Wang. RBBP6 increases radioresistance and serves as a therapeutic target for preoperative radiotherapy in colorectal cancer. Cancer Science 2018; 109(4): 1075 doi: 10.1111/cas.13516
|
| 7 |
Sepehr Khorasani, Arun Nagarajan, Timothy Nguyen, Sami A. Chadi. Fundamentals of Anorectal Surgery. 2019; : 445 doi: 10.1007/978-3-319-65966-4_24
|
| 8 |
Jian-Hong Peng, Jun-Zhong Lin, Yu-Ming Rong, Ying Zhu, Yu-Xiang Deng, Yu-Jie Zhao, Zhen-Hai Lu, Xiao-Jun Wu, Zhi-Zhong Pan. Oxaliplatin-containing adjuvant chemotherapy improves the survival of locally advanced rectal cancer patients with pathological complete response after pre-operative chemoradiotherapy. Gastroenterology Report 2018; 6(3): 195 doi: 10.1093/gastro/goy009
|
| 9 |
Chi Huang, Mingkun Jiang, Yan Li, Chaoyang Tang, Xiang Ma, Xiangkun Huan. Can Elevated Pretreatment Serum Carcinoembryonic Antigen Levels Serve as a Potential Biomarker Guiding Adjuvant Chemotherapy in Rectal Cancer Patients With ypTis-3N0 After Neoadjuvant Radiotherapy and Surgery?. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.705460
|
| 10 |
Patricio M. Polanco, Ali A. Mokdad, Hong Zhu, Michael A. Choti, Sergio Huerta. Association of Adjuvant Chemotherapy With Overall Survival in Patients With Rectal Cancer and Pathologic Complete Response Following Neoadjuvant Chemotherapy and Resection. JAMA Oncology 2018; 4(7): 938 doi: 10.1001/jamaoncol.2018.0231
|
| 11 |
Patricio Polanco, Sergio Huerta. Omitting adjuvant chemotherapy in patients with rectal cancer who received neoadjuvant chemoradiation followed by total mesorectal excision and achieved a pathological complete response. The American Journal of Surgery 2018; 216(2): 387 doi: 10.1016/j.amjsurg.2017.03.019
|
| 12 |
Radhika Kainthla, Sergio Huerta. Adjuvant chemotherapy for ypT0N0M0 rectal cancer following chemoradiotherapy and total mesorectal excision. Anti-Cancer Drugs 2016; 27(9): 819 doi: 10.1097/CAD.0000000000000400
|
| 13 |
Ioana Hălmaciu, Andrei Suciu Bogdan, Cristian Russu, Vlad Olimpiu Butiurcă, Nicolae Bacalbașa, Simu Patricia Maria Luminița, Nicolescu Cosmin, Călin Molnar. Current Topics in Colorectal Surgery. 2023; doi: 10.5772/intechopen.99580
|
| 14 |
Dongxu Lei, Zhanzhen Liu, Xinyi Kang, Ziwei Zeng, Hao Xie, Tanxing Cai, Fujin Ye, Li Xiong, Wenxin Li, Zhenxing Liang, Xiaobin Zheng, Shuangling Luo, Huashan Liu, Eiji Sakai. Clinical Association of Negative Lymph Nodes With Adjuvant Chemotherapy in Patients With T3N0 Rectal Cancer. Gastroenterology Research and Practice 2025; 2025(1) doi: 10.1155/grp/3241615
|
| 15 |
Joan Maurel, Leire Pedrosa, Jordi Camps. Controversia en neoadyuvancia y cáncer de recto. Cirugía Española 2019; 97(7): 361 doi: 10.1016/j.ciresp.2019.01.004
|
| 16 |
Qingguo Li, Dakui Luo, Ji Zhu, Lifeng Yang, Qi Liu, Yanlei Ma, Lei Liang, Sanjun Cai, Zhen Zhang, Xinxiang Li. ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6289-6
|
| 17 |
Jiaolin Zhou, Huizhong Qiu, Guole Lin, Yi Xiao, Bin Wu, Wenming Wu, Xiyu Sun, Junyang Lu, Guannan Zhang, Lai Xu, Yuchao Liu. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center. International Journal of Colorectal Disease 2016; 31(6): 1163 doi: 10.1007/s00384-016-2579-5
|
| 18 |
Joan Maurel, Leire Pedrosa, Jordi Camps. The Controversy of Neoadjuvant Therapy in Rectal Cancer. Cirugía Española (English Edition) 2019; 97(7): 361 doi: 10.1016/j.cireng.2019.01.011
|